AU2002212555A1 - Yeast derived vaccine against ipnv - Google Patents

Yeast derived vaccine against ipnv

Info

Publication number
AU2002212555A1
AU2002212555A1 AU2002212555A AU1255502A AU2002212555A1 AU 2002212555 A1 AU2002212555 A1 AU 2002212555A1 AU 2002212555 A AU2002212555 A AU 2002212555A AU 1255502 A AU1255502 A AU 1255502A AU 2002212555 A1 AU2002212555 A1 AU 2002212555A1
Authority
AU
Australia
Prior art keywords
vaccines
ipnv
vaccine
polypeptide
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212555A
Inventor
Suzanne Breeman
Marie Beagley Labus
William Thomas Melvin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Aberdeen
Original Assignee
University of Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0027644A external-priority patent/GB0027644D0/en
Priority claimed from GB0030765A external-priority patent/GB0030765D0/en
Application filed by University of Aberdeen filed Critical University of Aberdeen
Publication of AU2002212555A1 publication Critical patent/AU2002212555A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

Disclosed are processes for producing a vaccine for use against infectious pancreatic necrosis virus (IPNV) in fish, which process comprises culturing a yeast host cell which expresses, and preferably secretes, an IPNV polypeptide, and formulating the polypeptide as a vaccine (preferably by using, or partially purifying) the supernatant. Such vaccines have advantages over vaccines produced in bacteria. Also disclosed are vaccines based VP3 and VP2var proteins, optionally in combination with antigens protective against other fish diseases. The invention further provides related materials (e.g. primers, vectors and host cells) and methods and uses of the vaccines for prophylaxis and therapy.
AU2002212555A 2000-11-11 2001-11-12 Yeast derived vaccine against ipnv Abandoned AU2002212555A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0027644 2000-11-11
GB0027644A GB0027644D0 (en) 2000-11-11 2000-11-11 Fish vaccine
GB0030765A GB0030765D0 (en) 2000-12-14 2000-12-14 Fish vaccine
GB0030765 2000-12-14
PCT/GB2001/004986 WO2002038770A1 (en) 2000-11-11 2001-11-12 Yeast derived vaccine against ipnv

Publications (1)

Publication Number Publication Date
AU2002212555A1 true AU2002212555A1 (en) 2002-05-21

Family

ID=26245278

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212555A Abandoned AU2002212555A1 (en) 2000-11-11 2001-11-12 Yeast derived vaccine against ipnv

Country Status (8)

Country Link
EP (1) EP1334197B1 (en)
AT (1) ATE494377T1 (en)
AU (1) AU2002212555A1 (en)
CA (1) CA2428027C (en)
DE (1) DE60143810D1 (en)
DK (1) DK1334197T3 (en)
NO (1) NO333007B1 (en)
WO (1) WO2002038770A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03008563A (en) * 2001-03-23 2005-03-07 Advanced Bionutrition Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins.
US7317142B2 (en) 2002-12-13 2008-01-08 Prodi Gene, Inc. Immunization of fish with plant-expressed recombinant proteins
WO2005035558A2 (en) * 2003-10-07 2005-04-21 Michel Thiry Piscirickettsia salmonis antigens and use thereof
CA2615139A1 (en) * 2004-10-01 2006-04-13 Michel Thiry Piscirickettsia salmonis antigens and use thereof
CA2673355A1 (en) 2006-12-20 2008-11-20 Advanced Bionutrition Corporation Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast
JP2010514412A (en) * 2006-12-22 2010-05-06 ソリューシオネス バイオテクノロジカス イノヴァシオン リミターダ DNA fish vaccine
WO2009077577A2 (en) 2007-12-19 2009-06-25 Schering-Plough Limited Vaccine antigens from piscirickettsia salmonis
CA2885333C (en) 2012-09-26 2021-02-09 Fvg Limited Subunit immersion vaccines for fish
EP3589725A1 (en) * 2017-02-28 2020-01-08 Vib Vzw Means and methods for oral protein delivery
CN115804837B (en) * 2022-02-24 2023-06-20 中国水产科学研究院黑龙江水产研究所 Infectious pancreatic necrosis adjuvant vaccine and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165925A (en) * 1989-05-02 1992-11-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Vaccine for immunizing fish against infectious pancreatic necrosis virus

Also Published As

Publication number Publication date
CA2428027C (en) 2012-09-11
NO20032097L (en) 2003-07-10
ATE494377T1 (en) 2011-01-15
EP1334197A1 (en) 2003-08-13
DK1334197T3 (en) 2011-04-04
WO2002038770A1 (en) 2002-05-16
EP1334197B1 (en) 2011-01-05
DE60143810D1 (en) 2011-02-17
NO333007B1 (en) 2013-02-18
CA2428027A1 (en) 2002-05-16
NO20032097D0 (en) 2003-05-09

Similar Documents

Publication Publication Date Title
WO2007024941A3 (en) Polyvalent vaccine
AU2003244855A1 (en) Method to enhance an immune response of nucleic acid vaccination
HK1083635A1 (en) Animal protein free media for cultivation of cells
MXPA05009096A (en) Animal-free cell culture method.
SI1951296T2 (en) Cell-derived viral vaccines with low levels of residual cell dna by betapropiolactone
HK1142093A1 (en) Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
WO2003024480A3 (en) In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
WO2006031264A3 (en) Siv and hiv vaccination using rhcmv- and hcmv-based vaccine vectors
AU4482200A (en) Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
WO2003082183A3 (en) Protein-based streptococcus pneumoniae vaccines
AU2002212555A1 (en) Yeast derived vaccine against ipnv
WO2005035558A3 (en) Piscirickettsia salmonis antigens and use thereof
EP1434862A4 (en) Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the cns
Stuart et al. Cassette-based presentation of SIV epitopes with recombinant gas vesicles from halophilic archaea
EP1852125A3 (en) Neisserial vaccine compositions and methods
ATE354370T1 (en) INACTIVATED IMMUNOGENIC BACTERIAL WHOLE CELL COMPOSITIONS
AU4149699A (en) Use of inactivated immunosuppressive and/or angiogenic immunogenic proteins, preparation method and pharmaceutical or vaccine uses
IL148741A0 (en) Vaccine
WO2008097267A3 (en) Vaccines against vesicular stomatitis
WO2004054508A3 (en) Immunogenic compositions including rough phenotype brucella host strains and complementation dna fragments
AU5573196A (en) A pluripotent vaccine against enveloped viruses
WO2002088338A3 (en) Method for replicating the hepatitis c virus
EP1310551A4 (en) Virus-like micrograins and process for producing the same
GB2369618B (en) Live vaccine expressing antigens using phoP or pagC promoters
AR248047A1 (en) Vaccines based on modified bovine herpesvirus type i